{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:35:40Z","timestamp":1793658940588,"version":"4.5.1"},"reference-count":40,"publisher":"Scientific Scholar","issue":"4","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of King Saud University - Science"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jksus.2022.101965","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T17:00:16Z","timestamp":1647450016000},"page":"101965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells"],"prefix":"10.25259","volume":"34","author":[{"given":"Sayed Sartaj","family":"Sohrab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif Aly","family":"El-Kafrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esam Ibraheem","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"10.1016\/j.jksus.2022.101965_b0005","unstructured":"Alnylam Pharmaceuticals, 2020. Vir and Alnylam Expand Collaboration to Advance RNAi Therapeutics for the Treatment of Coronavirus Infection, Including Covid-19. Available online at: https:\/\/investors.alnylam.com\/press-release?id= 24656."},{"key":"10.1016\/j.jksus.2022.101965_b0010","series-title":"Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)","author":"Aleem","year":"2022"},{"issue":"9","key":"10.1016\/j.jksus.2022.101965_b0015","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s00134-020-06202-3","article-title":"Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset","volume":"46","author":"Azoulay","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jksus.2022.101965_b0020","doi-asserted-by":"crossref","unstructured":"Bappy et al., 2021. Designing potential siRNA molecule for the nucleocapsid(N) gene silencing of different SARS-CoV-2 strains of Bangladesh: Computational approach. Comput. Biol. Chem.. 92, 107486.","DOI":"10.1016\/j.compbiolchem.2021.107486"},{"key":"10.1016\/j.jksus.2022.101965_b0025","doi-asserted-by":"crossref","unstructured":"Bellaousov et al., 2013. RNA structure: Web servers for RNA secondary structure prediction and analysis. Nucl. Acids Res., 41(Web Server issue), W471\u2013W474. https:\/\/doi.org\/10.1093\/nar\/gkt290.","DOI":"10.1093\/nar\/gkt290"},{"key":"10.1016\/j.jksus.2022.101965_b0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","article-title":"Therapeutic miRNA and siRNA: moving from bench to clinic as next generation meicine","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Mol. Therapy. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.jksus.2022.101965_b0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12250-020-00221-6","article-title":"Computational Identification of Small Interfering RNA Targets in SARS-CoV-2","volume":"35","author":"Chen","year":"2020","journal-title":"Virol. Sinica."},{"issue":"1","key":"10.1016\/j.jksus.2022.101965_b0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygeno.2020.12.021","article-title":"A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2","volume":"113","author":"Chowdhury","year":"2021","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.jksus.2022.101965_b0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10123-020-00146-w","article-title":"RNA interference as a promising treatment against SARS-CoV-2","volume":"24","author":"Donia","year":"2021","journal-title":"Int. Microbiol."},{"key":"10.1016\/j.jksus.2022.101965_b0050","doi-asserted-by":"crossref","unstructured":"El-Kafray et al., 2021. In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells.Molecules. (Basel, Switzerland),26(9), 2610.","DOI":"10.3390\/molecules26092610"},{"issue":"1","key":"10.1016\/j.jksus.2022.101965_b0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24435-8","article-title":"Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies","volume":"12","author":"Greaney","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jksus.2022.101965_b9000","article-title":"A Computational Approach for Predicting Role of Human MicroRNAs in MERS-CoV Genome","volume":"967946","author":"Hasan","year":"2014","journal-title":"Advances in bioinformatics"},{"issue":"7","key":"10.1016\/j.jksus.2022.101965_b0060","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"W1","key":"10.1016\/j.jksus.2022.101965_b0065","doi-asserted-by":"crossref","first-page":"W35","DOI":"10.1093\/nar\/gkz412","article-title":"HNADOCK: a nucleic acid docking server for modelling RNA\/DNA-RNA\/DNA 3D complex structures","volume":"47","author":"He","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.jksus.2022.101965_b0070","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.ymthe.2021.05.004","article-title":"A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19","volume":"29","author":"Idris","year":"2021","journal-title":"Mol. Therapy"},{"key":"10.1016\/j.jksus.2022.101965_b0075","doi-asserted-by":"crossref","unstructured":"Khanali, J., Mohammadreza, A-K., Yasaman, A., Monire, J., Jafar, K., 2020. An aptamer\/ siRNA Chimera against The SARS-CoV-2: A Dual Therapeutic Strategy for The Virus Neutralizing and RNA Interfering. Research Square. https:\/\/doi.org\/10.21203\/rs.3.rs-76450\/v1.","DOI":"10.21203\/rs.3.rs-76450\/v1"},{"issue":"20","key":"10.1016\/j.jksus.2022.101965_b0080","first-page":"3377","article-title":"Forna (force-directed RNA): Simple and effective online RNA secondary structure diagrams","volume":"31","author":"Kerpedjiev","year":"2015","journal-title":"Bioinformatics (Oxford, England)."},{"issue":"9","key":"10.1016\/j.jksus.2022.101965_b0085","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1111\/all.14850","article-title":"Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation","volume":"76","author":"Khaitov","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jksus.2022.101965_b0090","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ijbiomac.2022.01.059","article-title":"The Omicron (B.1.1.529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: insights from structural and simulation data","volume":"200","author":"Khan","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.jksus.2022.101965_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-021-03662-x","article-title":"Emerging SARS-CoV-2 variants of concern and potential intervention approaches","volume":"25","author":"Khateeb","year":"2021","journal-title":"Critical Care (London, England)."},{"key":"10.1016\/j.jksus.2022.101965_b0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fgene.2012.00102","article-title":"siRNA design software for a target gene-specific RNA interference","volume":"3","author":"Naito","year":"2012","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.jksus.2022.101965_b0105","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-10-392","article-title":"siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect","volume":"10","author":"Naito","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.jksus.2022.101965_b0110","doi-asserted-by":"crossref","unstructured":"Niktab et al., 2021. Design of advanced siRNA therapeutics for the treatment of COVID-19. Meta Gene. 29, 100910.","DOI":"10.1016\/j.mgene.2021.100910"},{"issue":"1","key":"10.1016\/j.jksus.2022.101965_b0115","article-title":"Prediction of potential small interfering RNA molecules for silencing of the spike gene of SARS-CoV-2","volume":"153","author":"Panda","year":"2021","journal-title":"Indian J. Med. Res."},{"issue":"2","key":"10.1016\/j.jksus.2022.101965_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/acg2.107","article-title":"An in silico analysis of effective siRNAs against COVID\u201019 by targeting the leader sequence of SARS\u2010CoV\u20102","volume":"4","author":"Pandey","year":"2021","journal-title":"Adv. Cell Gene Ther."},{"key":"10.1016\/j.jksus.2022.101965_b0125","doi-asserted-by":"crossref","unstructured":"Rohani et al., 2021. DisCoVering potential candidates of RNAi-based therapy for COVID-19 using computational methods.PeerJ.9, e10505.","DOI":"10.7717\/peerj.10505"},{"key":"10.1016\/j.jksus.2022.101965_b0130","doi-asserted-by":"crossref","unstructured":"Shawan et al., 2021. Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2. Infect., Genetics Evol.: J. Mol. Epidemiol. Evolut. Genetics Inf. Dis., 93, 104951.","DOI":"10.1016\/j.meegid.2021.104951"},{"issue":"3","key":"10.1016\/j.jksus.2022.101965_b0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.cr.7290286","article-title":"Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs","volume":"15","author":"Shi","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.jksus.2022.101965_b9010","article-title":"Designing and evaluation of MERS-CoV siRNAs in HEK-293 Cell line","author":"Sohrab","year":"2020","journal-title":"J. Infect. Public Health."},{"issue":"2","key":"10.1016\/j.jksus.2022.101965_b0140","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.sjbs.2020.11.066","article-title":"In silico prediction and experimental validation of siRNAs targeting ORF1ab of MERS-CoV in Vero cell line","volume":"28","author":"Sohrab","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"issue":"32","key":"10.1016\/j.jksus.2022.101965_b0145","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.2174\/1381612827999210111194101","article-title":"in silico prediction and designing of potential siRNAs to be used as antivirals against SARS-CoV-2","volume":"27","author":"Sohrab","year":"2021","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.jksus.2022.101965_b0150","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jiph.2020.12.018","article-title":"Designing and evaluation of MERS-CoV siRNAs in HEK-293 cell line","volume":"14","author":"Sohrab","year":"2021","journal-title":"J. Infection Public Health"},{"issue":"1","key":"10.1016\/j.jksus.2022.101965_b0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1381612823666171109112307","article-title":"Design and Delivery of Therapeutic siRNAs: application to MERS-Coronavirus","volume":"24","author":"Sohrab","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"7874","key":"10.1016\/j.jksus.2022.101965_b0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jksus.2022.101965_b0165","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3390\/v13102030","article-title":"Inhibition of SARS-CoV-2 replication by a small interfering RNA targeting the leader sequence","volume":"13","author":"Tolksdorf","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jksus.2022.101965_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00916","article-title":"Prospects for RNAi therapy of COVID-19","volume":"8","author":"Uluda\u011f","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jksus.2022.101965_b0175","unstructured":"World Health Organization (2022): WHO, https:\/\/www.who.int\/health-topics\/coronavirus#tab=tab. Last accessed on 26.1.2022."},{"key":"10.1016\/j.jksus.2022.101965_b0180","unstructured":"World Health Organization (2021): https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern."},{"issue":"6","key":"10.1016\/j.jksus.2022.101965_b9015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.7150\/ijbs.59151","article-title":"Developing effective siRNAs to reduce the expression of key viral genes of COVID-19","volume":"17","author":"Wu and Luo","year":"2021","journal-title":"International journal of biological sciences."},{"issue":"2","key":"10.1016\/j.jksus.2022.101965_b0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11684-020-0767-8","article-title":"Coronavirus disease 2019 (COVID-19): a clinical update","volume":"14","author":"Zhou","year":"2020","journal-title":"Front. Med."}],"container-title":["Journal of King Saud University - Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101836472200146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101836472200146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T21:29:48Z","timestamp":1751059788000},"score":1,"resource":{"primary":{"URL":"https:\/\/jksus.org\/effect-of-insilico-predicted-and-designed-potential-sirnas-on-inhibition-of-sars-cov-2-in-hek-293-cells\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S101836472200146X"],"URL":"https:\/\/doi.org\/10.1016\/j.jksus.2022.101965","relation":{},"ISSN":["1018-3647"],"issn-type":[{"value":"1018-3647","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells","name":"articletitle","label":"Article Title"},{"value":"Journal of King Saud University - Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jksus.2022.101965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"101965"}}